Source: International Congress 2017 – Gene signatures in bronchial diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Turan (Stevenage, United Kingdom). A hypothesis driven approach investigating the interleukin-6 pathway in UBIOPRED severe asthma patients. 4941

Member's Comments

No comment yet.

Related content which might interest you: Dual-phenotype mouse model of COPD study suggest combined therapy targeting G-CSF and IL-17A could treat COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 The new approach to understand the role of IL-15 and BMP proteins in asthma remodelling based on methacholine challenge test evidence. Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 A new model to understand the concept physical activity for patients with COPD Source: Annual Congress 2011 - Physical activity, methodology and impact Year: 2011 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 The investigation of the role of interleukin (IL)-17 in COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 An algorithmic approach for the treatment of severe uncontrolled asthma Source: ERJ Open Res, 4 (1) 00125-2017; 10.1183/23120541.00125-2017 Year: 2018 The peculiarities of the cascade of the bronchial asthma patients‘ cytokines depending on the stage of disease Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006 IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Benralizumab restored expression of key molecules involved in steroid-resistance in patients with severe asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Which functional alteration is mainly the cause in determining dyspnoeain COPD patients? Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004 Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation Source: Eur Respir J, 54 (1) 1802390; 10.1183/13993003.02390-2018 Year: 2019